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Abstract
Background:  Accumulating evidence suggests an important role for the enzyme poly(ADP-
ribose) polymerase-1 (PARP-1) as an integral part of the gene expression regulatory machinery
during development and in response to specific cellular signals. PARP-1 might modulate gene
expression through its catalytic activity leading to poly(ADP-ribosyl)ation of nuclear proteins or by
its physical association with relevant proteins. Recently, we have shown that PARP-1 is activated
during T cell activation. However, the proposed role of PARP-1 in reprogramming T cell gene
expression upon activation remains largely unexplored.
Results: In the present study we use oligonucleotide microarray analysis to gain more insight into
the role played by PARP-1 during the gene expression reprogramming that takes place in T cells
upon activation with anti-CD3 stimulation alone, or in combination with anti-CD28 co-stimulation.
We have identified several groups of genes with expression modulated by PARP-1. The expression
of 129 early-response genes to anti-CD3 seems to be regulated by PARP-1 either in a positive (45
genes) or in a negative manner (84 genes). Likewise, in the presence of co-stimulation (anti-CD3 +
anti-CD28 stimulation), the expression of 203 genes is also regulated by PARP-1 either up (173
genes) or down (30 genes). Interestingly, PARP-1 deficiency significantly alters expression of genes
associated with the immune response such as chemokines and genes involved in the Th1/Th2
balance.
Conclusion: This study provides new insights into changes in gene expression mediated by PARP-
1 upon T cell activation. Pathway analysis of PARP-1 as a nuclear signalling molecule in T cells would
be of relevance for the future development of new therapeutic approaches targeting PARP-1 in the
acquired immune response.
Published: 16 April 2008
BMC Genomics 2008, 9:171 doi:10.1186/1471-2164-9-171
Received: 13 December 2007
Accepted: 16 April 2008
This article is available from: http://www.biomedcentral.com/1471-2164/9/171
© 2008 Saenz et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genomics 2008, 9:171 http://www.biomedcentral.com/1471-2164/9/171
Page 2 of 11
(page number not for citation purposes)
Background
T lymphocyte activation requires recognition through the
antigen-specific T cell receptor (TCR)/CD3 complex of
foreign peptides presented by self-MHC molecules on
antigen presenting cells in context with co-stimulatory sig-
nals mediated by co-stimulatory receptors such as CD28
[1]. The concurrent ligation of these receptors initiates sig-
nal transduction pathways that lead to the induction of a
complex array of kinases and phosphatases, and the
downstream activation of transcription factors such as NF-
κB, AP-1 and NFAT which play a critical role in repro-
gramming gene expression [2]. The overall result is the
proliferation, differentiation and activation of T cells.
However, T cells stimulated via the TCR/CD3 complex
alone do not become fully activated and can become aner-
gic or even apoptotic [3]. Transcriptional changes during
T cell stimulation are tightly regulated by a variety of
mechanisms involving not only interactions between a
complex network of transcription factors and cis-regula-
tory DNA regions, but also epigenetic changes in chroma-
tin structure including acetylation, phosphorylation,
methylation and ubiquitylation [4].
Accumulating evidence suggests an important role for the
enzyme poly(ADP-ribose) polymerase-1 (PARP-1) in the
regulation of gene expression during development and in
response to specific cellular signals [5,6] working at differ-
ent levels. PARP-1 belongs to a family of enzymes (PARP)
that, using NAD+ as a substrate, synthesize and transfer
homopolymers of ADP-ribose onto glutamic acid residues
of acceptor proteins mainly involved in chromatin struc-
ture and DNA metabolism. Poly(ADP-ribosyl)ation is ter-
minated by the release of extensively poly(ADP-
ribosyl)ated (negatively charged) PARP molecules from
DNA. ADP-ribose polymers are then subjected to degrada-
tion by poly(ADP-ribose) glycohydrolase (PARG) [6].
Poly(ADP-ribosyl)ation is therefore an immediate, cova-
lent, but transient post-translational modification of cel-
lular proteins playing and important role in epigenetic
regulation of chromatin structure and gene expression
under physiological conditions in which the integrity of
the DNA is maintained [6]. PARP-1 activity, responsible
for almost 90% of poly(ADP-ribosy)lation in the cell,
might modulate gene expression through poly(ADP-ribo-
syl)ation of its partner proteins or by its physical associa-
tion with relevant proteins such as transcription factors.
Regulation by PARP-1 has been described for different
transcription factors such as NF-κB [7,8], E2F-1 [9], C/
EBPalpha [10], YY-1 [11], RNA polymerase II-associated
factors [12], p53 [13] and NFAT [14]. Indeed, PARP-1 and
poly(ADP-rybosyl)ation play a critical role in the expres-
sion control of multiple NF-κB dependent genes involved
in the inflammatory response [15]. In addition, different
studies have analysed the effects of PARP-1 deficiency on
gene expression in fibroblasts [16-18], cardiomyocytes
[19], leukemia cells [20], glia [21], endothelial cells [15],
embryonic stem cell lines and liver tissue [22] at the
genome-wide level.
Recently, we have demonstrated that PARP-1 is activated
during T cell activation, modulating the activity of the
NFAT transcription factor [14]. In the present study we use
oligonucleotide microarray analysis to gain more insight
into the role played by PARP-1 during the gene expression
reprogramming that takes place in T cells upon activation
with anti-CD3-stimulation alone, or in combination with
anti-CD28 co-stimulation. These two stimulation condi-
tions would allow us to analyse the role of PARP-1 in the
modulation of genes upon NFAT activation under condi-
tions in which both AP-1 and NF-κB are fully activated
(anti-CD3 + anti-CD28 co-stimulation) or poorly acti-
vated (anti-CD3 alone). T cells co-stimulated with anti-
CD3 + anti-CD28 develop an overlapping transcription
network with anti-CD3 stimulated T lymphocytes, but co-
stimulatory signalling quantitatively alters components of
the TCR/CD3 complex-induced signals [23]. Therefore,
PARP-1 could synergize with different transcription fac-
tors in order to stimulate or repress gene expression in
both stimulation conditions. We have identified several
groups of genes, whose expression is modulated by PARP-
1 either in a positive or a negative manner. Interestingly,
PARP-1 deficiency significantly alters expression of genes
associated with the immune response such as chemokines
and genes involved in the Th1/Th2 balance.
Results and Discussion
Transcriptional programs in Parp-1-/- vs Parp-1+/+ T cells in 
response to antigen receptor stimulation
In order to study the role of PARP-1 in the transcriptional
regulation of T cells, we have analysed the gene expression
profiles in splenic T cells derived from PARP-1-wild-type
(Parp-1+/+) and PARP-1-deficient (Parp-1-/-) mice under
both resting and antigen receptor stimulation conditions,
using oligonucleotide microarray technology. Total RNA
prepared from resting or stimulated cells was purified,
reverse transcribed and amplified by in vitro transcription
in the presence of biotinylated nucleotides, and the
labeled cRNA was hybridized on Affymetrix oligonucle-
otide chips (murine genome 430A 2.0) containing over
22600 probe sets representing transcripts from over
14000 well-characterized mouse genes. Only those differ-
ences in RNA abundance that were reproducible in inde-
pendent experiments with different batches of cells and
represented by a change of 1.5-fold or greater (p-value <
0.05) were considered.
At a basal level, we found 93 genes (0.66%) that differed
in their expression between Parp-1+/+ and Parp-1-/- T cells.
This percentage is quite similar to the change in the basal
expression level observed between primary Parp-1+/+ andBMC Genomics 2008, 9:171 http://www.biomedcentral.com/1471-2164/9/171
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Parp-1-/- fibroblasts [18]. The expression of 50 of these
genes in T cells was higher in Parp-1-/- than in Parp-1+/+ T
cells (negatively regulated by PARP-1), while the expres-
sion of 43 genes, obviously including the Parp-1 gene
itself, was lower in Parp-1-/- compared to Parp-1+/+ T cells
(positively regulated by PARP-1) (Table 1). The specific
genes that were differentially expressed in Parp-1-/- vs
Parp-1+/+ T cells are listed in the Additional files 1 and 2.
In addition, all data are deposited in the ArrayExpress
database [24] with accession number E-MEXP-1237. We
did not observe genes overlapping between the report on
primary fibroblast and our present results. Similar
absence of overlap has been reported recently by Ogino et
al, between fibroblasts and ES cells [22]. This may be pos-
sibly due to differences in the cell linages examined in
these different experiments.
To characterize the gene expression program in T cells
responding to antigen receptor stimulation, T cells from
both genotypes were subjected to stimulation for 3.5 h
with a plate-bound antibody to CD3 alone, or in combi-
nation with an antibody to CD28 and expression results
were normalized to the unstimulated conditions. Short
stimulation times have been shown to induce important
changes in T cells gene expression programs [25,26]. CD3
stimulation modulated a significant number of early-
response genes (1168) (8.3% of all genes represented in
the microarray) in Parp-1+/+ T cells, up-regulating 755
and concomitantly down-regulating 413 transcripts,
while in Parp-1-/- T cells 958 of genes (6.8%) were mod-
ulated, up-regulating 656 genes and down-regulating 302
transcripts. On the other hand, CD3 stimulation in the
context of CD28 co-stimulatory signal, modulated a sig-
nificant number of early-response genes (1085) (7.8%) in
Parp-1+/+ T cells, up-regulating 722 and concomitantly
down-regulating 363 transcripts, while in Parp-1-/- T cells
1137 of genes (8.1%) were modulated, up-regulating 669
genes and down-regulating 468 transcripts.
Identification of PARP-1-dependent genes during early T 
cell activation
Transcriptional changes during T lymphocyte activation
have also been characterized in the past [25], and it is
beyond the scope of this paper to provide a discussion of
all of the observed changes and their biological implica-
tions. However, comparison of the gene expression pro-
grams evoked by activation in Parp-1+/+ and Parp-1-/-T
cells shows that 129 early-response genes to anti-CD3
seem to be PARP-1-dependent (fold-change >1.5; F-test p-
value<0.05) and regulated by PARP-1 either in a positive
(higher expression in Parp-1+/+ than in Parp-1-/- T cells)
(45 genes) or in a negative manner (higher expression in
Parp-1-/- than in Parp-1+/+ T cells) (84 genes) (Table 1).
Likewise, in the presence of co-stimulation (anti-CD3 +
anti-CD28 mAbs stimulation), the expression of 203
genes is also regulated by PARP-1 either in a positive (173
genes) or in a negative manner (30 genes) (Table 1). In
addition, these data are listed in the Additional files 3 and
4. Interestingly, response to anti-CD3 alone resulted in a
higher number of genes negatively regulated by PARP-1
than those regulated positively. However, anti-CD3 stim-
ulation in the presence of anti-CD28 co-stimulation pro-
duces the opposite effect, favouring expression of genes
regulated positively by PARP-1 (Table 1). These results
could be related with a different role of PARP-1 in the reg-
ulation of specific transcription factors involved in those
signalling pathways. Thus, T cell stimulation via the TCR/
CD3 complex alone seem to be sufficient for NFAT but
not for optimal NF-κB or AP-1 activation. We have
recently demonstrated that PARP-1 inhibition seems to
modulate in an opposite manner NFAT and NF-κB-
dependent transcriptional activity in T cells, improving
NFAT [14] and inhibiting NF-κB activities (data not
shown). However, the complexity of the NFAT and NF-κB
families, together with the regulation of genes by both
transcriptional factor members precludes ascribing the
described PARP-1-dependent genes to a unique and direct
effect on NFAT or NF-κB dependent transcriptional activ-
ity.
Table 1: PARP-1 dependent genes in T cellsa
Stimulation No. of genes
Total Positive regulationb Negative regulationb
None 93 43 50
Anti-CD3 129 45 84
Anti-CD3+anti-CD28 203 173 30
a Genes were classified as PARP-1 dependent genes when their expression was change by a factor of at least 1.5 (F-test<0.05) between Parp-1+/+ 
and Parp-1-/- cells in the microarrays analysis. bPositive regulation was considered when the expression of a particular gene was higher in the 
presence of PARP-1 than in its absence. Likewise, genes expressed at higher level in the absence of PARP-1 than in its presence were considered 
negatively regulated by PARP-1.BMC Genomics 2008, 9:171 http://www.biomedcentral.com/1471-2164/9/171
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Twenty one genes were dependent on PARP-1 for
response to both anti-CD3 and anti-CD3 + anti-CD28
stimulation (Figures 1A and 1B). Eleven of these genes
were positively regulated by PARP-1 while 4 of them were
negatively regulated by PARP-1 in response to either anti-
CD3 or anti-CD3 + anti-CD28 stimulation. However, 4
genes (Cxcl9, Set, Pim1, and Sfrs2) were regulated posi-
tively by PARP-1 in response to CD3 stimulation alone,
but the same genes were regulated negatively by PARP-1
in the presence of co-stimulation through CD28. Like-
wise, 2 genes (Itga6 and Parp-12) were regulated nega-
tively by PARP-1 in response to CD3 stimulation but
positively by PARP-1 in response to anti-CD3 + anti-
CD28 stimulation (Fig. 1B). We confirmed expression
changes for some genes by Real-time PCR. Although there
were differences in the absolute fold-change values
detected by the two methods, PCR results correlated well
with the differential gene expression data produced using
Affymetrix GeneChips (Figure 1C).
Automatic functional annotation of PARP-1-dependent
genes in response to either anti-CD3 or anti-CD3 + anti-
CD28 stimulation was performed based on Ingenuity
software. Although this type of annotation is very useful
to obtain a description of the transcriptome, it can be mis-
leading if the absolute number of genes that fall into each
class is used as the only factor for selection of relevant
classes. Consequently, we identified which Gene-Ontol-
ogy (GO) terms were significantly over-represented in
each activation condition (anti-CD3 alone or anti-CD3 in
combination with anti-CD28). As shown in the examples
in Figure 2, more PARP-1-dependent genes than expected
by chance were involved in certain processes or functions.
The bars indicate whether there are more PARP-1-depend-
Gene expression profile analysis of Parp-1+/+ and Parp-1-/- activated T cells Figure 1
Gene expression profile analysis of Parp-1+/+ and Parp-1-/- activated T cells. (A) Venn diagram showing the numbers of PARP-1-dependent genes in T cells upon stimu-
lation with anti-CD3 mAb alone or in combination with anti-CD28 mAb. (B) Expression maps including the genes dependent on PARP-1 in response to both anti-CD3 and anti-
CD3 + anti-CD28 stimulation. Red indicates higher expression in Parp-1+/+ T cells compared to Parp-1-/- T cells (positive regulation by PARP-1) while green indicates higher 
expression in Parp-1-/- T cells compared to Parp-1+/+ T cells (negative regulation by PARP-1). Numbers on the left column indicate the fold-change expression in Parp-1+/+ T cells 
compared to Parp-1-/- T cells. (C) Real-time PCR analysis of representative genes. Samples were normalized according to Gapdh expression levels. The y-axis represents fold-
change of activated versus resting cells for both Parp-1+/+ (white bars) and Parp-1-/- (black bars) T cells. Results represent the mean value ± SD of two independent experiments. 
The ratio of gene expression in Parp-1+/+ over Parp-1-/- cells (positive number) or the ratio of gene expression in Parp-1-/- over Parp-1+/+ cells (negative number) is indicated 
above each pair of bars.
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ent genes with a given GO term than expected with a ran-
dom distribution in each activation condition.
Interestingly, the highest differences were found for genes
involved in lymphocyte activation and immune response,
with little differences in genes involved in metabolism.
PARP-1 deficiency affects the expression of genes involved 
in the immune response pathway in T cells
A subset of PARP-1 dependent genes in response to anti-
CD3 stimulation (14 out of 129; ~11%) and in response
to anti-CD3 + anti-CD28 stimulation (24 out of 203;
~12%) encode for molecules involved directly in the
immune response pathway (Fig. 3A) as determined using
the Ingenuity software. To validate the array data, we also
evaluated expression of several of these genes by quantita-
tive Real-time PCR. Although there were differences in the
absolute fold-change values detected by the two methods,
PCR results correlated well with the differential gene
expression data produced using Affymetrix GeneChips
(Fig. 3B and 3C). Discordant results were found between
the arrays and PCR for only Gbp7 gene in response to
anti-CD3 + anti-CD28 stimulation.
In response to stimulation through CD3 alone or in com-
bination with mAb to CD28 a significantly increased
expression of IL-4 was detected in Parp-1+/+ compared to
Parp-1-/- T cells (Fig. 3A). This result was further confirmed
by Real-time PCR (Fig. 3B and 3C). In addition, T cells
purified from Parp-1+/+ and Parp-1-/- mice were stimulated
for 24 hours with anti-CD3, alone or in combination with
anti-CD28 mAb, and IL-4 released in the supernatants was
measured by ELISA (Fig. 4). The results verified the effect
of PARP-1 deficiency on the expression levels of IL-4
obtained at the mRNA level in the microarray and Real-
time PCR experiments. Overall, our data suggest an
important role for PARP-1 in the regulation of IL-4 expres-
sion. IL-4 is a major Th2 effector cytokine and a key pro-
moter of Th2 development [4]. Th1 and Th2 cells are
characterized by the types of cytokines that they pro-
duced. IFN-gamma is the hallmark of Th1 cells which are
involved in the immune response against intracellular
microoganisms. On the other hand, Th2 effector cells
secrete IL-4, IL-5 and IL-13 being involved in immune
response to helminth infections as well as to IgE-depend-
ent hypersensitivity reactions. Interestingly, the expres-
sion of IFN-gamma mRNA seem to be increased in Parp-
1-/- T cells. Expression of several Th1 chemokines such as
Xcl1, Ccl4 and Ccl9 seem to be also increased en Parp-1-/-
T cells in response to anti-CD3 + anti-CD28 activation
(Fig. 3). Therefore, the absence of PARP-1 seems to bias T
cell response to a Th1 phenotype. However, our microar-
ray data did not reveal any difference in the expression of
other Th2 cytokines such as IL-5, IL-10 and IL-13 between
Parp-1-/-  and Parp-1+/+  T cells, suggesting that PARP-1
could specifically control IL-4 gene expression which
might act on Th1 differentiation by supressing IL-12bR
expression and IFN-gamma secretion. Previous studies
have demonstrated the requirement of Slam in IL-4 pro-
duction by T cells [27]. Similarly, Irf4 gene expression was
also found to be higher in Parp-1+/+ than in Parp-1-/- T cells
after stimulation with anti-CD3 + anti-CD28 (Fig. 3A).
Irf4 seems to enhance IL-4, but not IL-2 promoter activity
[28]. Whether PARP-1 controls IL-4 expression through
an interaction with cis-regulatory elements or chromatin
remodelling at IL-4 locus remains to be elucidated.
Reduction of IL-4 production by lung cells has been
reported in OVA-challenged Parp-1-/- mice compared with
wild-type mice as well as in wild-type mice treated with
the PARP activity inhibitors TIQ-A [29], although phar-
macological inhibition of PARP activity using the PJ34
Gene Ontology term enrichment analysis of PARP-1 depend- ent genes upon T cell activation Figure 2
Gene Ontology term enrichment analysis of PARP-1 
dependent genes upon T cell activation. More genes 
than expected by chance were involved in certain processes 
or functions in response to anti-CD3 stimulation alone (black 
bar) or in response to anti-CD3 + anti-CD28 stimulation 
(grey bar). The length of the bar indicates the ratio between 
numbers of observed PARP-1 dependent genes in each proc-
esses or functions and the number expected by chance.
1 0 864202468 1 0
metabolism
intracellular_signaling_cascade
transcription._DNA−dependent
protein_kinase_cascade
immune_response
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inhibitor in peripheral blood lymphocytes did not sup-
press IL-4 production [30]. These discrepancies might be
associated to side effects of the different inhibitors used in
these studies. Further studies are therefore needed to
determine whether PARP-1 is a new player in the epige-
netic regulation of IL-4 by T cells [4] or is involved on the
immune response associated with a Th2 bias. Autoinmu-
nity seem to be associated to an immune response bised
to the differentiation and activation of Th1 and/or Th17
effectors T cells. PARP-1 seems to positively control Ifi203
expression even in the absence or presence of CD28-stim-
ulation (Fig. 3 and data not shown). In sharp contrast,
Ifi202b was preferentially expressed in Parp-1-/- stimu-
lated T cells. A high expression of Ifi202b and a low
expression of Ifi203 and was also observed in B6.Nba2
autoimmune prone mice [31]. Therefore, PARP-1 could
play a role in the consequence of autorecognition acting
through Ifi203 and Ifi202b gene regulation.
T cell proliferation is impaired in the absence of PARP-1
T cell proliferation is a hallmark of T cell activation. To
determine whether PARP-1-dependent transcriptional
regulation influences T cell function, we analyzed the pro-
liferation response of Parp-1-/- and control T cells after in
vitro stimulation with anti-CD3 mAb alone or in combi-
nation with anti-CD28 mAb. Figure 5A shows a modest,
PARP-1 dependent genes in T cells involved in the immune response Figure 3
PARP-1 dependent genes in T cells involved in the immune response. (A) Expression maps including all the genes belonging to GO terms "immune response". Red indi-
cates higher expression in Parp-1+/+ T cells compared to Parp-1-/- T cells (positive regulation by PARP-1) while green indicates higher expression in Parp-1-/- T cells compared to 
Parp-1+/+ T cells (negative regulation by PARP-1). Numbers in the left column indicate the fold-change expression in Parp-1+/+ T cells compared to Parp-1-/- T cells. (B) Real-time 
PCR analysis of representative genes in response to anti-CD3 stimulation or (C) in response to anti-CD3 + anti-CD28 stimulation. Samples were normalized according to Gapdh 
expression levels. The y-axis represents fold-change of activated versus resting cells for both Parp-1+/+ (white bars) and Parp-1-/- (black bars) T cells. Results represent the mean 
value ± SD of two independent experiments. The ratio of gene expression in Parp-1+/+ over Parp-1-/- cells (positive number) or the ratio of gene expression in Parp-1-/- over 
Parp-1+/+ (negative number) cells is indicated above each pair of bars.
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but statistically significant, decrease in T cell proliferation
upon stimulation in Parp-1-/- compared to control cells
while T cells from both genotypes show similar suscepti-
bility to death upon activation suggesting an intrinsic
defect in proliferation in the absence of PARP-1 (Fig. 5B).
The role of PARP-1 in apoptosis is variable, depending on
the stimuli and the type of cells. Oliver et al. reported that
primary bone marrow Parp-1-/- cells are extremely sensi-
tive to apoptosis induced by an alkylating agent but not
by a topoisomerase I inhibitor CPT-11 or by interleukin-3
removal [32]. However, Wang et al. reported that Parp-1-/
- cells lymphoid cells display normal apoptotic sensitivity
after treatment with various apoptotic agents [33]. In
addition, recently we have demonstrated that PARP-2
deficiency affects CD4+CD8+  apoptosis susceptibility
while we did not found any effect on Parp-1-/- mice [34].
Although proliferation is a complex process that requires
modulation of different genes, some of the PARP-1
dependent genes identified in this analysis may help to
understand the mutant phenotypes observed, thereby
establishing a possible link between the transcriptome
and the proliferation phenotype. Thus, the reduced
expression of Slamf1 and Rel [35] genes in the absence of
PARP-1 might be related with the reduced proliferative
response of Parp-1-/- T cells.
Conclusion
This study provides new insights into the role of PARP-1
in T cell activation by modulating gene expression. Using
a microarray based approach, we identified 129 genes
whose expression in response to anti-CD3 stimulation is
PARP-1 dependent. Likewise, expression of 203 genes
upon anti-CD3 + anti-CD28 stimulation was also depend-
ent of PARP-1. By using automatic functional annotation
of PARP-1-dependent genes we identified GO terms that
were significantly over-represented in each activation con-
dition (anti-CD3 alone or anti-CD3 in combination with
anti-CD28), including a group of genes involved in lymph
immune response. Functional dissection should help to
unravel the remaining mysteries of PARP-1 as a signalling
molecule at the nuclear level in T cells and might be essen-
tial for future development of new therapeutic approaches
targeting PARP-1 in the acquired immune response.
Methods
Mice
The generation of Parp-1-/- mouse strain (129/Sv × C57BL/
6J) has been described previously [36]. Parp-1-/- mice were
back-crossed into the C57BL/6J background for seven
generations. The animals were kept under standardised
conditions and tap water and mouse chow were provided
ad libitum. All experiments were performed with splenic T
cells from 8–10 week old mice on a C57BL/6J back-
ground. The experimental procedure was approved by the
ethics committee of the University of Murcia and per-
formed in accordance with institutional animal care
guidelines that are in compliance with the National Insti-
tutes of Health's Guide for the Care and Use of Laboratory
Animals.
Isolation and stimulation of primary T cells
Primary T cells were isolated from spleens of Parp-1-/- and
Parp-1+/+ mice by magnetic depletion of non-T cells using
a MACS Pan-T Cell isolation kit, according to the manu-
facturer's instructions (Miltenyi Biotec, Bergisch Glad-
bach, Germany). Purity was assessed by flow cytometry
analysis using antibodies against CD3, CD4 and CD8 and
all preparations were more than 98% pure T cells. The
cells were activated with plate-bound hamster anti-mouse
CD3 (clone 145-2C11) (5 μg/ml) in the absence or the
presence of hamster anti-mouse CD28 (clone 37.51) (5
μg/ml) both from BD PharMingen (San Diego, CA) and
cultured in RPMI 1640 medium (BioWhittaker) supple-
mented with 10% FCS, 2 mM L-glutamine, 5 × 10-5 M 2-
mercaptoethanol, 2.5 μg/ml fungizone, 100 IU/ml peni-
cillin, and 10 μg/ml streptomycin, all from Sigma (St.
Louis, MO).
Flow cytometry
Cell suspensions were washed in PBS, resuspended in PBS
containing 0.5% BSA and incubated with antibodies on
ice for 30 min. Incubation with biotin-labelled antibodies
was followed by incubation with streptavidin-Tri-color
conjugate (Caltag, Burlingame, CA). Phycoerythrin (PE)-
conjugated rat anti-mouse CD4 (GK1.5), fluorescein iso-
IL-4 production in both Parp-1+/+ and Parp-1-/- T cells Figure 4
IL-4 production in both Parp-1+/+ and Parp-1-/- T cells. 
T cells were stimulated for 24 h with anti-CD3 or anti-CD3 
+ anti-CD28 mAbs. The level of IL-4 was measured by ELISA. 
An experiment representative of three experiments is 
shown. Results represent the mean value ± SD. * P < 0.05 in 
t-test.
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thiocyanate (FITC)-conjugated rat anti-mouse CD8 (53-
6.7) and the biotin-conjugated hamster anti-mouse CD3
(145-2C11) were from BD PharMingen. For apoptosis
detection, cells were washed with PBS and the presence of
apoptotic cells was analyzed using the annexin V-FITC
apoptosis detection kit (Pharmigen) according to the
manufacturer's instructions. All cell analysis was per-
formed with a FACSort flow cytometer and CellQuest
software (BD).
Microarray analysis
T cells were pooled from either 4 independent Parp-1+/+
mice or 4 independent Parp-1-/- mice (every pool com-
posed of equal amounts of cells from each mice) in each
independent experiment. Cells were stimulated with
plate-bound anti-CD3 alone or in combination with anti-
CD28 for 3.5 h. Total RNA was isolated from cells by
using a Rneasy Total RNA Isolation kit (Qiagen, Valencia,
CA) following the manufacturer's instructions. Total RNA
(8 μg) was subjected to reverse transcription with Super-
script (Life Technologies, Grand Island, NY), using a T7-
(dT)24 primer containing a T7 RNA polymerase promoter
site. Biotinylated complementary RNA was made from 1
μg of cDNA and then fragmented to approximately 50–
100 nucleotides, following Affymetrix's instructions. 15
micrograms of the in vitro transcripts with appropriate
T cell proliferation and apoptosis in Parp-1+/+ and Parp-1-/- T cells Figure 5
T cell proliferation and apoptosis in Parp-1+/+ and Parp-1-/- T cells. (A) Splenic T cells from Parp-1+/+ (white bars) and 
Parp-1-/- (black bars) were stimulated with plate-bound anti-CD3 mAb alone or in combination with anti-CD28 mAb for 24 h, 
48 h and 72 h. Proliferation was measured by 3H-thymidine uptake during the last 12 h of culture. Data are representative of 3 
separate experiments carried on in triplicate. Results represent the mean value ± SD. *P < 0.05 in t-test. (B) Apoptosis of T 
cells from Parp-1+/+ (white bars) and Parp-1-/- (black bars) was detected by FITC-Annexin-V and Propidium iodide staining and 
flow cytometric analysis at 24 hours after stimulation. Results represent the mean value ± SD of two independent experiments.
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controls and spikes were hybridized for 16 h at 45°C with
constant rotation at 60 rpm to an Affymetrix MOE-430A
2.0 array (Affymetrix, Santa Clara, CA), which contains
probes for 22600 known genes and expressed sequences
tags (ESTs). Chips were washed and stained by using the
EukGE-WS2v4 protocol on an Affymetrix fluidics station.
The stain included streptavidin-phycoerythrin (10 μg/ml)
(Molecular Probes, Eugene, OR) and biotinylated goat
anti-streptavidin (3 μg/ml) (Vector Laboratories, Burlin-
game, CA). Chips were scanned with Agilent Gene Array
Scanner and visualized and analyzed using Affymetrix
software (Affymetrix Microarray Suite 5.0; Affymetrix
Data Mining Tool 3.0; Affymetrix MicroDB 3.0). Expres-
sion values of transcripts were normalized, according to
the total intensity on the chip. Only those differences in
RNA abundance that were reproducible in at least two
independent experiments with different batches of cells
(each batch represents a pool of 4 mice) and representing
a change of 1.5-fold or greater (p-value <0.05) were con-
sidered. The utility of pooling biological samples in
microarray experiments for measurement of groups of
individuals using few arrays when primary interest is not
on the individual, but rather on characteristics of the pop-
ulation from which certain individuals are obtained, has
been previously reported [37].
Quantitative RT-PCR
Total RNA was isolated from the cells by using the Rneasy
Total RNA Isolation kit (Qiagen), with on-column DNase
I (Qiagen) digestion, following the manufacturer's
instructions. cDNA synthesis, and Quantitative real-time
PCR was performed as previously described [15]. Two
independent experiments with different batches of cells
were carried out. Each batch represents a pool of 3 inde-
pendent mice with equal amount of cells from each
mouse. Specific primers for the different genes are
described in Table 2. Each gene was normalized to the
Gapdh gene. This gene has been shown to remain
unchanged under our experimental conditions in our
microarray analysis. In addition, it has been shown that at
early activation time (< 4 hours), Gapdh expression
remains unchanged in response to anti-CD3 in human T
cells [38]. The relative changes in gene expression were
calculated using the 2-ΔΔCT method [39]. Briefly, cycle
threshold (CT) value means the number of PCR cycles
required for the detection of fluorescence signal to exceed
a fixed threshold. The data were analysed using ΔΔCT = CT
target - CT gapdh. With this calculation ΔΔCT equals to log2
ratio, therefore value 1 of ΔΔCT corresponds to a 2-fold
change.
Proliferation assay
T cells were seeded in 96-well plates (2 × 105 cells/well)
and stimulated with anti-CD3 alone or in combination
with anti-CD28 mAb as described above. The cultures
were conducted for 24 h, 48 h and 72 h and pulsed with
1 μCi [3H]thymidine (Moravek Biochemicals, Brea, CA)
for the last 12 h of culture. Radioactivity incorporated into
DNA was measured by liquid scintillation counting.
Experiments were performed in triplicate.
ELISA
To determine the amount of secreted IL-4, cells were
seeded in 96-well plates at subclonfluent density over-
night. The enzyme-linked immunosorbent assays (ELISA)
for IL-4 was carried out using cell-free supernatants from
untreated or anti-CD3 or anti-CD3 + anti-CD28 treated
cells, according to the manufacturer's protocol (Quantik-
ine® mouse IL-4 immunoassay, R&D Systems, Minneapo-
lis, MN).
Statistical analysis
Cel files obtained from MAS software were normalised
using robust multiarray analysis (RMA). RMA has been
demonstrated to provide improved precision over the
default algorithms provided by Affymetrix, which gener-
ates MAS5.0 signals [40]. Differential expression was
assessed by using linear models and empirical Bayes mod-
erated F-statistics [41]. An interaction term was computed
to know which genes respond differently to each treat-
ment (anti-CD3 or anti-CD3-CD28) in PARP-1 mutant
phenotypes compared to wild-type cells. Selected genes
Table 2: Primer sets used for Quantitative real time PCR analysis
Gene Forward primer Reverse primer
Egr-2 GCCAAGGCCGTAGACAAAATC CCACTCCGTTCATCTGGTCA
Nr4a1 TGAGACCCTATCCTCCAGCG TCTGGCTCGGGGAGAAGTG
Prnp ATGGCGAACCTTGGCTACTG CCTGAGGTGGGTAACGGTTG
Il12rb1 ATGGCTGCTGCGTTGAGAA AGCACTCATAGTCTGTCTTGGA
Il-4 GGTCTCAACCCCCAGCTAGT GCCGATGATCTCTCTCAAGTGAT
Ccl4 TTCCTGCTGTTTCTCTTACACCT CTGTCTGCCTCTTTTGGTCAG
Rel CAGAATTTGGACCAGAACGCA TGCTGTTCACCCACATTGAAAG
Slamf1 CAGAAATCAGGGCCTCAAGAG CACTGGCATAAACTGTGGTGG
Gbp7 TCCTGTGTGCCTAGTGGAAAA CAAGCGGTTCATCAAGTAGGAT
Ccl9 CCCTCTCCTTCCTCATTCTTACA AGTCTTGAAAGCCCATGTGAAABMC Genomics 2008, 9:171 http://www.biomedcentral.com/1471-2164/9/171
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were subjected to a GO enrichment analysis computing
the ratio of observed vs number of genes expected for each
GO term, using a Fisher Test from the GO-STATS statisti-
cal package. All these analyses were performed using the
Bioconductor Package run in the R statistical program-
ming environment [42]. IL-4 production and T cell prolif-
eration results are presented as mean values ± SD.
Statistical differences between groups were evaluated by
the two-tailed Student's t test. A p-value < 0.05 was con-
sidered as statistically significant.
Additional data files
The following additional data are available with the
online version of this paper. Additional data files 1 and 2
are tables listing the genes whose expression at basal level
was higher in Parp-1-/- than in Parp-1+/+T cells and the
genes whose expression was lower in Parp-1-/- compared
to Parp-1+/+ T cells, respectively. Additional data files 3
and 4 are tables listing the PARP-1 dependent genes in T
cells upon stimulation with anti-CD3 mAb alone or in
combination with anti-CD28 mAb, respectively.
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